Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data
Clinical trial NCT06754865 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06754865
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-11-01
- Enrollment
- 1140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.